Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Forman

Showing results (1031-1040 of 1,052) with videos related to

Pageof 106
Sort By:
Biorxiv : the Preprint Server for Biology|November 24, 2025
Immunometabolic determinants of long-term response in leukemia patients receiving CD19 CAR T cell therapyLior Goldberg, Eric R Haas, Jiaqi Wu, et al.
Nature Metabolism|June 27, 2022
Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivoMichael P Murphy, Hülya Bayir, Vsevolod Belousov, et al.
British Journal of Haematology|October 6, 2017
Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative studyMohamed A Kharfan-Dabaja, Monzr M Al Malki, Uday Deotare, et al.
American Journal of Hematology|March 7, 2023
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusionsIbrahim Aldoss, Michelle Afkhami, Dongyun Yang, et al.
Frontiers in Immunology|March 7, 2025
Impact of hyperhydration on fluid overload and hematopoietic cell transplant after post-transplant cyclophosphamide-based graft-versus-host-disease prophylaxisDiana T Samuels, Janny M Yao, Yazeed Samara, et al.
Nature Medicine|June 12, 2024
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trialTanya B Dorff, M Suzette Blanchard, Lauren N Adkins, et al.
Transplantation and Cellular Therapy|March 30, 2026
Disability-Free Survival: A Novel Morbidity Endpoint for Older Adult Allogeneic Hematopoietic Cell TransplantationJorge M Ramos Perez, Haoyue Shan, Dongyun Yang, et al.
Biorxiv : the Preprint Server for Biology|July 12, 2026
Radioligand therapy in combination with CAR T cells overcomes the heterogeneous immunosuppressive prostate tumor microenvironmentJiangyue Liu, Iveta Fajnorova, Yuwei Ren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for LymphomaChristopher J Gibson, R Coleman Lindsley, Vatche Tchekmedyian, et al.
Haematologica|November 7, 2024
Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemiaIbrahim Aldoss, Jianying Zhang, Kathryn Shimamoto, et al.
Pageof 106

Showing results (1031-1040 of 1,052) with videos related to

Sort By:
Pageof 106
Biorxiv : the Preprint Server for Biology|November 24, 2025
Immunometabolic determinants of long-term response in leukemia patients receiving CD19 CAR T cell therapyLior Goldberg, Eric R Haas, Jiaqi Wu, et al.
Nature Metabolism|June 27, 2022
Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivoMichael P Murphy, Hülya Bayir, Vsevolod Belousov, et al.
British Journal of Haematology|October 6, 2017
Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative studyMohamed A Kharfan-Dabaja, Monzr M Al Malki, Uday Deotare, et al.
American Journal of Hematology|March 7, 2023
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusionsIbrahim Aldoss, Michelle Afkhami, Dongyun Yang, et al.
Frontiers in Immunology|March 7, 2025
Impact of hyperhydration on fluid overload and hematopoietic cell transplant after post-transplant cyclophosphamide-based graft-versus-host-disease prophylaxisDiana T Samuels, Janny M Yao, Yazeed Samara, et al.
Nature Medicine|June 12, 2024
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trialTanya B Dorff, M Suzette Blanchard, Lauren N Adkins, et al.
Transplantation and Cellular Therapy|March 30, 2026
Disability-Free Survival: A Novel Morbidity Endpoint for Older Adult Allogeneic Hematopoietic Cell TransplantationJorge M Ramos Perez, Haoyue Shan, Dongyun Yang, et al.
Biorxiv : the Preprint Server for Biology|July 12, 2026
Radioligand therapy in combination with CAR T cells overcomes the heterogeneous immunosuppressive prostate tumor microenvironmentJiangyue Liu, Iveta Fajnorova, Yuwei Ren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for LymphomaChristopher J Gibson, R Coleman Lindsley, Vatche Tchekmedyian, et al.
Haematologica|November 7, 2024
Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemiaIbrahim Aldoss, Jianying Zhang, Kathryn Shimamoto, et al.
Pageof 106